• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核细胞通过脂肪细胞因子内脂素/NAMPT 对 R5 与 X4 HIV 产生不同的免疫压力。

Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT.

机构信息

Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium.

出版信息

PLoS One. 2012;7(4):e35074. doi: 10.1371/journal.pone.0035074. Epub 2012 Apr 6.

DOI:10.1371/journal.pone.0035074
PMID:22493731
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3320877/
Abstract

BACKGROUND

The immune system exerts a diversifying selection pressure on HIV through cellular, humoral and innate mechanisms. This pressure drives viral evolution throughout infection. A better understanding of the natural immune pressure on the virus during infection is warranted, given the clinical interest in eliciting and sustaining an immune response to HIV which can help to control the infection. We undertook to evaluate the potential of the novel HIV-induced, monocyte-derived factor visfatin to modulate viral infection, as part of the innate immune pressure on viral populations.

RESULTS

We show that visfatin is capable of selectively inhibiting infection by R5 HIV strains in macrophages and resting PBMC in vitro, while at the same time remaining indifferent to or even favouring infection by X4 strains. Furthermore, visfatin exerts a direct effect on the relative fitness of R5 versus X4 infections in a viral competition setup. Direct interaction of visfatin with the CCR5 receptor is proposed as a putative mechanism for this differential effect. Possible in vivo relevance of visfatin induction is illustrated by its association with the dominance of CXCR4-using HIV in the plasma.

CONCLUSIONS

As an innate factor produced by monocytes, visfatin is capable of inhibiting infections by R5 but not X4 strains, reflecting a potential selective pressure against R5 viruses.

摘要

背景

免疫系统通过细胞、体液和先天机制对 HIV 施加多样化的选择压力。这种压力在整个感染过程中推动病毒进化。鉴于人们对引发和维持对 HIV 的免疫反应以帮助控制感染的临床兴趣,因此有必要更好地了解感染过程中病毒自然受到的免疫压力。我们着手评估新型 HIV 诱导的单核细胞衍生因子内脂素在病毒群体的先天免疫压力中调节病毒感染的潜力。

结果

我们表明,内脂素能够在体外选择性地抑制巨噬细胞和静止 PBMC 中 R5 HIV 株的感染,同时对 X4 株的感染保持漠不关心甚至有利。此外,内脂素在病毒竞争设置中对 R5 与 X4 感染的相对适应性产生直接影响。提出内脂素与 CCR5 受体的直接相互作用作为这种差异作用的潜在机制。内脂素诱导的可能体内相关性通过其与 CXCR4 利用 HIV 在血浆中占优势相关联得到说明。

结论

作为单核细胞产生的先天因子,内脂素能够抑制 R5 但不能抑制 X4 株的感染,反映了对 R5 病毒的潜在选择压力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/e809ec7cb49b/pone.0035074.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/b660295b42e4/pone.0035074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/711f4cb8bd93/pone.0035074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/ec598ad2e08e/pone.0035074.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/251214e84eb0/pone.0035074.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/e809ec7cb49b/pone.0035074.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/b660295b42e4/pone.0035074.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/711f4cb8bd93/pone.0035074.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/ec598ad2e08e/pone.0035074.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/251214e84eb0/pone.0035074.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b314/3320877/e809ec7cb49b/pone.0035074.g005.jpg

相似文献

1
Monocytes contribute to differential immune pressure on R5 versus X4 HIV through the adipocytokine visfatin/NAMPT.单核细胞通过脂肪细胞因子内脂素/NAMPT 对 R5 与 X4 HIV 产生不同的免疫压力。
PLoS One. 2012;7(4):e35074. doi: 10.1371/journal.pone.0035074. Epub 2012 Apr 6.
2
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.在感染过程中,开关(R5 到 R5X4/X4-嗜性)和非开关(仅 R5-嗜性)HIV-1 群体之间的分子进化差异。
Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.
3
Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.HIV-1 感染者血浆中存在具有不同核心受体使用偏好的复制型次要变异体。
J Virol. 2020 Jun 1;94(12). doi: 10.1128/JVI.00193-20.
4
HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.在体外被CCR5嗜性和CXCR4嗜性HIV-1感染的直肠乙状结肠组织和扁桃体组织中,HIV-1发病机制有所不同。
AIDS. 2007 Jun 19;21(10):1263-72. doi: 10.1097/QAD.0b013e3281864667.
5
Δ20 IFITM2 differentially restricts X4 and R5 HIV-1.Δ20IFITM2 对 X4 和 R5 HIV-1 具有不同的限制作用。
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7112-7117. doi: 10.1073/pnas.1619640114. Epub 2017 Jun 19.
6
Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.与同一患者共存的利用CCR5的病毒变体相比,最近出现的利用CXCR4的人类免疫缺陷病毒1型毒株的中和敏感性增加。
J Virol. 2007 Jan;81(2):525-31. doi: 10.1128/JVI.01983-06. Epub 2006 Nov 1.
7
High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.高 CD4(+) T 细胞表面 CXCR4 密度是 HIV-1 感染过程中 R5 向 X4 转变的危险因素。
J Acquir Immune Defic Syndr. 2010 Dec 15;55(5):529-35. doi: 10.1097/QAI.0b013e3181f25bab.
8
CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells.CCR5和CXCR4的表达与X4和R5型HIV-1感染相关,但在Th1和Th2细胞中并非持续复制。
AIDS. 2001 Oct 19;15(15):1941-9. doi: 10.1097/00002030-200110190-00005.
9
The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.两种人类CXCR4亚型表现出不同的HIV受体活性:对X4毒株出现的影响。
J Immunol. 2014 Oct 15;193(8):4188-94. doi: 10.4049/jimmunol.1303298. Epub 2014 Sep 17.
10
Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.用R5和X4型HIV-1双重攻击的人源化小鼠表现出优先的R5病毒血症以及CCR5(+)CD4(+) T细胞的X4感染受限。
Microbes Infect. 2015 May;17(5):378-86. doi: 10.1016/j.micinf.2015.02.002. Epub 2015 Apr 1.

引用本文的文献

1
Nicotinamide phosphoribosyltransferase in NAD metabolism: physiological and pathophysiological implications.烟酰胺磷酸核糖转移酶在NAD代谢中的作用:生理及病理生理意义
Cell Death Discov. 2025 Aug 8;11(1):371. doi: 10.1038/s41420-025-02672-w.
2
Long-Term Elite Controllers of HIV-1 Infection Exhibit a Deep Perturbation of Monocyte Homeostasis.长期的HIV-1感染精英控制者表现出单核细胞稳态的深度紊乱。
Int J Mol Sci. 2025 Apr 22;26(9):3926. doi: 10.3390/ijms26093926.
3
Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.

本文引用的文献

1
Visfatin--a review.内脏脂肪素——综述。
Eur Rev Med Pharmacol Sci. 2011 Jan;15(1):9-14.
2
The R5 to X4 coreceptor switch: a dead-end path, or a strategic maneuver? Lessons from a game theoretic analysis.R5 向 X4 辅助受体的转换:死胡同还是策略性举措?博弈论分析的启示。
Bull Math Biol. 2011 Oct;73(10):2339-56. doi: 10.1007/s11538-010-9625-1. Epub 2011 Mar 4.
3
Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans.
烟酰胺磷酸核糖基转移酶通过促进小鼠巨噬细胞 M2 极化来引发博来霉素诱导的肺纤维化。
Theranostics. 2024 Apr 28;14(7):2794-2815. doi: 10.7150/thno.94482. eCollection 2024.
4
The Effect of Visfatin on the Functioning of the Porcine Pituitary Gland: An In Vitro Study.内脂素对猪脑垂体功能的影响:一项体外研究。
Cells. 2023 Dec 14;12(24):2835. doi: 10.3390/cells12242835.
5
Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker.细胞外烟酰胺磷酸核糖基转移酶:在疾病病理生理学中的作用及其作为生物标志物的特性。
Front Immunol. 2023 Oct 17;14:1268756. doi: 10.3389/fimmu.2023.1268756. eCollection 2023.
6
Visfatin in the porcine pituitary gland: expression and regulation of secretion during the oestrous cycle and early pregnancy.猪脑垂体中的内脂素:发情周期和早孕期间分泌的表达和调节。
Sci Rep. 2023 Oct 25;13(1):18253. doi: 10.1038/s41598-023-45255-4.
7
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.细胞外烟酰胺磷酸核糖转移酶 (eNAMPT) 中和可拮抗乳腺癌中的 T 细胞免疫逃逸。
J Immunother Cancer. 2023 Oct;11(10). doi: 10.1136/jitc-2023-007010.
8
NAD Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies.NAD代谢与免疫调节:炎症性肠病治疗的新方法
Antioxidants (Basel). 2023 Jun 7;12(6):1230. doi: 10.3390/antiox12061230.
9
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease.烟酰胺磷酸核糖转移酶(NAMPT)和烟酰胺磷酸核糖基转移酶(NAPRT)血清水平可预测炎症性肠病患者对抗肿瘤坏死因子(TNF)治疗的反应。
Front Med (Lausanne). 2023 Feb 1;10:1116862. doi: 10.3389/fmed.2023.1116862. eCollection 2023.
10
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease.细胞外 NAPRT 对活检证实的非酒精性脂肪性肝病中晚期纤维化检测的预测作用。
Int J Mol Sci. 2023 Jan 7;24(2):1172. doi: 10.3390/ijms24021172.
白细胞是循环烟酰胺磷酸核糖基转移酶(NAMPT)/前 B 细胞集落(PBEF)/内脏脂肪素在人体中将肥胖与炎症联系起来的主要来源。
Diabetologia. 2011 May;54(5):1200-11. doi: 10.1007/s00125-010-2042-z. Epub 2011 Feb 6.
4
Transcriptome analysis of monocyte-HIV interactions.单核细胞-人类免疫缺陷病毒相互作用的转录组分析。
Retrovirology. 2010 Jun 14;7:53. doi: 10.1186/1742-4690-7-53.
5
X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells.在原代细胞感染过程中,X4和R5型HIV-1在进入细胞后对尿嘧啶DNA糖基化酶有不同的需求。
J Biol Chem. 2010 Jun 11;285(24):18603-14. doi: 10.1074/jbc.M109.090126. Epub 2010 Apr 6.
6
Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.前 B 细胞集落增强因子/NAMPT/内脏脂肪素在炎症和肥胖相关疾病中的作用。
Curr Pharm Des. 2010 Jun;16(17):1913-20. doi: 10.2174/138161210791208947.
7
Understanding the HIV coreceptor switch from a dynamical perspective.从动力学角度理解 HIV 辅助受体转换。
BMC Evol Biol. 2009 Nov 30;9:274. doi: 10.1186/1471-2148-9-274.
8
Adaptation of HIV-1 to human leukocyte antigen class I.人类免疫缺陷病毒1型对人类白细胞抗原I类分子的适应性
Nature. 2009 Apr 2;458(7238):641-5. doi: 10.1038/nature07746. Epub 2009 Feb 25.
9
Large-scale expression and purification of the major HIV-1 coreceptor CCR5 and characterization of its interaction with RANTES.主要HIV-1共受体CCR5的大规模表达与纯化及其与RANTES相互作用的表征
Protein Expr Purif. 2008 Oct;61(2):155-62. doi: 10.1016/j.pep.2008.06.001. Epub 2008 Jun 8.
10
CD4 mimetic miniproteins: potent anti-HIV compounds with promising activity as microbicides.CD4模拟微蛋白:具有作为杀菌剂的潜在活性的强效抗HIV化合物。
J Antimicrob Chemother. 2008 Apr;61(4):818-26. doi: 10.1093/jac/dkn042. Epub 2008 Feb 12.